PRRT2 and Alzheimer disease: Aβ is shown to decrease brain PKC levels and activity (Lee et al., 2004; Liron et al., 2007; Hongpaisan et al., 2011), while PKC hypofunction conversely leads to the defects of APP processing and significantly contributes to AD pathophysiology and progression (Pascale et al., 1998).